Autocrine effect of androgen on proliferation of an androgen responsive prostatic carcinoma cell line, LNCAP: Role of interleukin-6

Endocrinology

Volumn 138, Issue 11, 1997, Pages 5071-5074

  Okamoto, Masato ^a   Lee, Chung ^a   Oyasu, Ryoichi ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; INTERLEUKIN 6;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; HORMONE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA;

EID: 0030780064     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.11.5653     Document Type: Article

References (14)

1. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu MT, Mirand EA, Murphy GP 1983 LNCaP model of human prostatic carcinoma. Cancer Res 43:1808-1817
2. Wilding G, Chen M, Gelmann E 1989 Aberrant response in vitro of hormone-responsive prostate cancer cells to anti-androgens. Prostate 14:103-115
3. Kokontis J, Kiyoshi I, Hiipakka RA, Liao S 1991 Expression and function of normal and LNCaP androgen receptors in androgen-insensitive human prostatic cancer cells. Altered hormone and antihormone specificity in gene transactivation. Receptor 1:271-280
4. Veldscholte J, Ris-Staplers C, Kuiper GGJM, Jester G, Berrevoets C, Classen E, van Fooij HCJ, Trapman J, Brinkman AO, Muler E 1990 A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 173:534-540
5. Sonnenschein C, Olea N, Pasanen ME, Sato AM 1989 Negative controls of cell proliferation: Human prostate cancer cells and androgens. Cancer Res 49:3474-3481
6. Lee C, Sutkowski DM, Sensiber JA, Zelner D, Kim I, Amsel I, Shaw N, Prins GS, Kozlowski JM 1995 Regulation of proliferation and production of prostate specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology 136:796-803
7. Kim IY, Kim JH, Zelner DJ, Ahn HJ, Sensibar JA, Lee C 1991 Transforming growth factor-β1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP. Endocrinology 137: 991-999
8. Okamoto M, Lee C, Oyasu R 1997 Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res 57: 141-146
9. Okamoto M, Oyasu R 1996 Effect of transfected interleukin-6 in non-tumorigenic and tumorigenic rat urothelial cell lines. Int J Cancer 68: 616-621
10. Mosmann T 1983 Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxity assays. J Immunol Methods 65: 55-63
11. Davies P, Eaton CL 1991 Regulation of prostate growth. J Endocrinol 131: 5-17
12. Kassen A, Kozlowski JM, Lee C 1995 Role of basic fibroblast growth factor in the autocrine regulation of LNCaP proliferation induced by dihydrotestosterone. Program of the 77th Annual Meeting of The Endocrine Society, Washington DC, p272(Abstract 1-639)
13. Lee C 1997 Cellular interactions in prostate cancer. Br J Urol 79 (suppl 1):21-27
14. Lee C, Shvrin DH, Kozlowski JM 1993 In vivo and in vitro approaches to study metastasis in human prostatic cancer. Cancer Metastasis Rev 12: 21-28